Tele-video to Improve Daily Activity (T-VIDA)

November 18, 2025 updated by: Noah J Webster, University of Michigan

Leveraging Social Networks: a Novel Physical Activity Intervention for Senior Housing

This pilot study will test the feasibility of pairing a social network-based approach with a 6-week Occupational Therapist (OT)-led intervention administered remotely (via Zoom) to increase physical function and activity among residents of a HUD subsidized independent-living senior housing community. The intervention is called Tele-Video to Improve Daily Activity (T-VIDA) and will be administered with two cohorts of residents in a single community. The study has two main goals: 1) To determine if an OT-led program administered remotely over the internet using Zoom is useful in helping residents increase their physical activity; and 2) to determine if involving respected members of the community in the program as Advisory Committee members has an impact on how much other residents participate in program activities and engage in behaviors discussed. The OT intervention will be comprised of a combination of adapted components from multiple evidence-based interventions including individual meetings with an OT and OT-led group sessions. To evaluate the intervention pre- and post-program interviews will be conducted with participants over the phone, and activity monitoring will be conducted after both the pre- and post-program interviews for 7-days using an activity monitoring device. The following hypotheses will be tested: 1) at least 75% (3 of 4) of identified residents will accept the invitation to serve on the Advisory Committee; 2) Advisory Committee Members will attend at least 2 of 3 committee meetings; 3) Participants will on average participate in at least 70% (7 of 10) of intervention activities; 4) Residents knowing one or more committee members at baseline will participate in more intervention activities compared to those who do not; and 5) The influence of knowing a committee member on participation will be greater among residents reporting more pain at baseline compared to those reporting less pain.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
8

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Locations

  • United States
    • Michigan
      • Ann Arbor, Michigan, United States, 48104
        • University of Michigan

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • resident of the senior housing community of focus
  • English-proficient
  • ambulatory with or without assistive device (e.g., cane, walker)

Exclusion Criteria:

  • requiring use of a wheelchair for ambulation;
  • requiring highly specialized equipment (e.g., spinal cord injury, leg amputation, wound vacuum assisted closure, heavy leg boot);
  • hospitalized within last 3 months;
  • has probable dementia (TICSm score <27);
  • requiring ongoing complicated treatments (e.g., home oxygen use >2 liters);
  • has active mental health condition judged to pose significant barrier to participation; and
  • meets CDC recommendations for physical activity (150+ minutes of moderate-intensity aerobic activity during typical week).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: occupational therapy intervention group
Behavioral: Tele-Video to Improve Daily Activity
Participants will be asked to meet individually with an Occupational Therapist (OT) via Zoom to assess activity performance, establish short-term activity goals, and outline an individualized home exercise program. Participants will also be asked to participate in 4 weekly one hour group sessions via Zoom that will include: 1) education; 2) OT facilitated discussion; and 3) activity demonstration, engagement and feedback. The following topics will be covered: mobility, physical activity, pain management, and energy conservation. Participants will be asked to meet individually with the OT via Zoom for 15-20 minutes weekly to answer questions. At the end, participants will be asked to again meet individually with the OT via Zoom to re-assess activity performance and revisit short-term activity goals and the individualized home exercise program. Advisory Committee Members will be asked to make note of intervention activities during their regular interactions with other participants.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Process Outcome - Advisory Committee Members Accept Invitation
Time Frame: 1 week pre-intervention
Number of originally identified potential Advisory Commitee Members who accept the invitation to serve on the committee. Possible scores range from 0 to 1.
1 week pre-intervention
Process Outcome - Advisory Committee Member Participation
Time Frame: Week 5 of intervention
Number of committee meetings attended by Advisory Committee Members. Possible scores range from 0 to 3.
Week 5 of intervention
Process Outcome - Individual Activity Participation
Time Frame: Immediately after the intervention, 6 weeks after the intervention started
Number of individual (one-on-one) intervention activities attended by participants. Possible scores range from 0 to 6.
Immediately after the intervention, 6 weeks after the intervention started
Process Outcome - Group Activity Participation
Time Frame: Immediately after the intervention, 6 weeks after the intervention started
Number of group intervention activities attended by participants. Possible scores range from 0 to 4.
Immediately after the intervention, 6 weeks after the intervention started
Process Outcome - Total Activity Participation
Time Frame: Immediately after the intervention, 6 weeks after the intervention started
Total number of intervention activities attended by participants (individual and group). Possible scores range from 0 to 10.
Immediately after the intervention, 6 weeks after the intervention started
Process Outcome - Number Acitivites Via Zoom
Time Frame: Immediately after the intervention, 6 weeks after the intervention started
Number of activities attended via zoom as opposed to calling in by telephone. Possible scores range from 0 to 10.
Immediately after the intervention, 6 weeks after the intervention started

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Change in Self-reported Physical Activity
Time Frame: 1 week pre and 1 week post the 6-week intervention
Modified Community Health Activities Model Program questionnaire. This includes 16 questions/items that measure the number of times and the frequency of each activity engaged in during a typical week in the past month. The response scale for each of the 16 items ranges from 1=less than 1 hour to 6=9 or more hours. On this scale, higher values represent a better outcome. A total self-reported physical activity score is calculated by averaging the score of all 16 items. The range for the total score also ranges from 1 to 6. Change will be measured by creating a difference score between the pre and post intervention total scores. Positive change scores represent a better outcome, i.e., an increase in self-reported physical activity.
1 week pre and 1 week post the 6-week intervention
Change in Perceived Barriers to Physical Activity
Time Frame: 1 week pre and 1 week post the 6-week intervention
This includes 17 questions/items that measure the degree to which specific things make it more difficult for participants to engage in 30 minutes of moderate intensity physical activity on 5 or more days a week. The response scale for each of the 17 items ranges from 1=not at all more difficult to 4=much more difficult. On this scale, lower values represent a better outcome. A total perceived barriers to physical activity score is calculated by averaging the score of all 17 items. The range for the total score also ranges from 1 to 4. Change will be measured by creating a difference score between the pre and post intervention total scores. Negative change scores represent a better outcome, i.e., a decrease in perceived barriers to physical activity.
1 week pre and 1 week post the 6-week intervention
Change in Pain Interference
Time Frame: 1 week pre and 1 week post the 6-week intervention
This includes 8 questions/items that measure how much pain interferes with daily activities. The response scale for each the 8 items ranges from 1=not at all to 5=very much. On this scale, lower values represent a better outcome. A total pain interference score is calculated by averaging the score of all 8 items. The range for the total score also ranges from 1 to 5. Change will be measured by creating a difference score between the pre and post intervention total scores. Negative change scores represent a better outcome, i.e., a decrease in pain interference.
1 week pre and 1 week post the 6-week intervention
Change in Pain Intensity
Time Frame: 1 week pre and 1 week post the 6-week intervention
This includes one question about how participants rate their pain on average using a scale ranging from 0=no pain to 10=the worst imaginable pain. Change will be measured by creating a difference score between the pre and post intervention scores.
1 week pre and 1 week post the 6-week intervention
Change in Physical Function Difficulty
Time Frame: 1 week pre and 1 week post the 6-week intervention
This includes a modified version of the National Health and Aging Trends Study disability and functioning measure. The measure includes 11 questions/items assessing difficulty performing self-care, mobility, and household activities. The response scale for each of the 11 items asking about difficulty doing these activities ranges from 1=none to 4=a lot. On this scale, lower values represent a better outcome. A total physical function difficulty score is calculated by averaging the score of all 11 items. The range for the total score also ranges from 1 to 4. Change will be measured by creating a difference score between the pre and post intervention total scores. Negative change scores represent a better outcome, i.e., a decrease in physical function difficulty.
1 week pre and 1 week post the 6-week intervention
Change in Self-efficacy in Activity
Time Frame: 1 week pre and 1 week post the 6-week intervention
This includes 10 questions/items that measure participants' confidence in doing a number of activities that will be discussed during the intervention. The response scale for each of the 10 items ranges from 1=not confident at all to 5=completely confident. On this scale, higher values represent a better outcome. A total self-efficacy in activity score is calculated by averaging the score of all 10 items. The range for the total score also ranges from 1 to 5. Change will be measured by creating a difference score between the pre and post intervention total scores. Positive change scores represent a better outcome, i.e., an increase in self-efficacy in activity.
1 week pre and 1 week post the 6-week intervention
Change in Percentage of Other Participants Known
Time Frame: 1 week pre and 1 week post the 6-week intervention
This will include a measure of the percentage of other participants each participant reports knowing. Possible scores range from 0 to 100. Change will be measured by creating a difference score between the pre and post intervention scores.
1 week pre and 1 week post the 6-week intervention
Change in Respect Level of Other Participants
Time Frame: 1 week pre and 1 week post the 6-week intervention
This will include a measure of how much respect on average participants have for the other participants that they report knowing. This question will be asked on a scale ranging from 1=respect them very much to 5=don't respect them at all. Change will be measured by creating a difference score between the pre and post intervention scores.
1 week pre and 1 week post the 6-week intervention
Change in Sedentary Behavior
Time Frame: 1 week pre and 1 week post the 6-week intervention
Participants will be asked to wear an accelerometer for 7 days following participation in pre- and post intervention interviews. Data from the accelerometers will be used to quantify the average amount of time that participants were sedentary per day over the 7 days. Change will be measured by creating a difference score between the pre and post intervention scores.
1 week pre and 1 week post the 6-week intervention
Change in Number of Steps
Time Frame: 1 week pre and 1 week post the 6-week intervention
Participants will be asked to wear an accelerometer for 7 days following participation in pre- and post intervention interviews. Data from the accelerometers will be used to quantify the average number of steps taken per day over the 7 days. Change will be measured by creating a difference score between the pre and post intervention scores.
1 week pre and 1 week post the 6-week intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
University of Michigan

Collaborators

Collaborators

An organization other than the sponsor that provides support for a clinical study. This support may include activities related to funding, design, implementation, data analysis, or reporting.
National Institute on Aging (NIA)

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Noah J Webster, PhD, University of Michigan

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
August 23, 2023

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
November 26, 2024

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
December 10, 2024

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
August 17, 2023

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
August 22, 2023

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
August 23, 2023

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
December 11, 2025

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
November 18, 2025

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
November 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • HUM00224610
  • 1K01AG062754-01A1 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Sharing Time Frame

Starting 6 months after publication

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Physical Inactivity

Clinical Trials on Tele-Video to Improve Daily Activity

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings